Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY: HIMS )

33.93 -0.78 (-2.25%)
Official Closing Price Updated: 7:00 PM EDT, Mar 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 21,357,556
Open 36.15
Bid (Size) 34.35 (1)
Ask (Size) 34.50 (29)
Prev. Close 34.71
Today's Range 32.77 - 37.28
52wk Range 11.20 - 72.98
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Check Out What Whales Are Doing With HIMS
Via Benzinga
Why Hims & Hers Health Stock Just Popped
Via The Motley Fool

Performance

YTD
+34.64%
+34.64%
1 Month
-24.21%
-24.21%
3 Month
+12.39%
+12.39%
6 Month
+122.20%
+122.20%
1 Year
+132.08%
+132.08%

More News

Read More
4 Top Stocks to Buy Under $100
Via The Motley Fool
Should You Buy Hims & Hers Stock on the Dip?
Via The Motley Fool
Hims & Hers Stock Is Down 50% From Its High, but Is This a Buying Opportunity?
Via The Motley Fool
The State of Weight Loss Drugs
Via The Motley Fool
Forecasting The Future: 15 Analyst Projections For Hims & Hers Health
Via Benzinga
Why Hims & Hers Stock Just Collapsed
Via The Motley Fool
Market Whales and Their Recent Bets on HIMS Options
Via Benzinga
Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
Via MarketBeat
Exposures Product Safety
3 Cold Stocks That Can Bounce Back This Week
Via The Motley Fool
MarketBeat Week in Review – 03/03 - 03/07
Via MarketBeat
Topics Economy
Exposures Interest Rates
This Could Be a Huge Blow to Hims & Hers Health Stock
Via The Motley Fool
Why Hims & Hers Health Stock Sank This Week
Via The Motley Fool
Hims & Hers Health Unusual Options Activity For February 28
Via Benzinga
Why Novo Nordisk Stock Outpaced the Market Today and Hims & Hers Lagged It
Via The Motley Fool
Why Is Hims & Hers Health Stock Trading Lower On Wednesday?
Via Benzinga
Exposures Product Safety
Novo Nordisk Slashes Wegovy Price, Undercutting Hims & Hers Health
Via Investor's Business Daily
Missed the Hims & Hers Rally? Clover Health Could Be Next
Via MarketBeat
EXCLUSIVE: February's 20 Most-Searched Tickers On Benzinga Pro – Where Do Tesla, Palantir, Alibaba, Nvidia Rank?
Via Benzinga
Tech Sector Hammered As Trump's Tariff Plans Spark Market Selloff: Nvidia, ARM, Super Micro Lead Tech Bloodbath
Via Benzinga
Topics Government World Trade
Exposures Political Tariff
Short Term Relief Likely
Via Talk Markets
Topics ETFs Stocks / Equities
Hims & Hers Stocks Sinks Despite Huge Revenue Growth. Is This a Buying Opportunity in the Stock?
Via The Motley Fool
Sixty Percent Of The Time, It Works Every Time
Via Talk Markets
Topics Stocks / Equities
Behind Hims Stock's Roller-Coaster Ride As Weight-Loss Drugs Battle Heats Up
Via Investor's Business Daily
Exposures Product Safety
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.